Literature DB >> 30668955

Hyptis verticillata attenuates dyslipidaemia, oxidative stress and hepato-renal damage in streptozotocin-induced diabetic rats.

Ironya Ogar1, Godwin Eneji Egbung2, Victor Udo Nna3, Item Justin Atangwho1, Edisua Hogan Itam1.   

Abstract

AIMS: Chronic hyperglycaemia in diabetes mellitus (DM) increases the production of free radicals which results in oxidative stress and related disorders such as cardiovascular diseases, compromised hepatic and renal functions. Hyptis verticillata reportedly demonstrated glucose lowering activity in previous studies. The present study therefore evaluated the effect of H. verticillata on hyperglycaemia-induced dyslipidaemia, hepatorenal distortions, oxidative stress, as well as calculated indices of cardiovascular function.
METHODS: Wistar rats employed for this study consisted of normoglycaemic and diabetic rats in nine experimental groups. The normoglycaemic and diabetic rats were either treated with metformin (500 mg/kg b.w.), quercetin (10 mg/kg b.w.), or ethanol extract of H. verticillata leaf (250 mg/kg b.w. and 500 mg/kg b.w.) administered orally for 28 days. KEY
FINDINGS: Results revealed that H. verticillata significantly lowered blood glucose level, attenuated dyslipidaemia, decreased atherogenic coefficient, atherogenic and coronary risk indices, and increased cardioprotective index in diabetic rats. Also, H. verticillata significantly decreased serum urea, creatinine, aspartate aminotransferase, alanine aminotransferase, alkaline phosphatase and unconjugated bilirubin levels, relative to untreated diabetic rats. Further, H. verticillata increased serum superoxide dismutase, catalase and glutathione peroxidase activities and glutathione level, and decreased malondialdehyde level in diabetic rats in a manner similar to metformin and quercetin. Histopathological investigation of the liver and kidney revealed restored hepatocytes and amelioration of congested interstitial blood vessel of the Bowman's space of the kidneys upon intervention with H. verticillata. SIGNIFICANCE: H. verticillata in addition to its anti-hyperglycaemic activity ameliorates oxidative stress, dyslipidaemia, atherogenicity and hepatorenal lesions in DM.
Copyright © 2019 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Antioxidant; Diabetes mellitus; Hepato-renal lesion; Hyptis verticillata; Oxidative stress

Mesh:

Substances:

Year:  2019        PMID: 30668955     DOI: 10.1016/j.lfs.2019.01.027

Source DB:  PubMed          Journal:  Life Sci        ISSN: 0024-3205            Impact factor:   5.037


  5 in total

Review 1.  Antidiabetic Potential of Plants from the Caribbean Basin.

Authors:  Vanessa Méril-Mamert; Alejandro Ponce-Mora; Muriel Sylvestre; Genica Lawrence; Eloy Bejarano; Gerardo Cebrián-Torrejón
Journal:  Plants (Basel)       Date:  2022-05-20

2.  Hypoglycemic, hepatoprotective, and hypolipidemic effects of hydroalcoholic extract of Eryngium billardieri root on nicotinamide/streptozotocin-induced type II diabetic rats.

Authors:  Samira Khani; Maasoume Abdollahi; Zeynab Asadi; Mohamad Nazeri; Mohammad Amin Nasiri; Hossein Yusefi; Abbas Moghadam; Hamid Heidari
Journal:  Res Pharm Sci       Date:  2021-03-05

3.  Terminalia catappa aqueous leaf extract reverses insulin resistance, improves glucose transport and activates PI3K/AKT signalling in high fat/streptozotocin-induced diabetic rats.

Authors:  Franklyn Nonso Iheagwam; Olawumi Toyin Iheagwam; Michael Kemjika Onuoha; Olubanke Olujoke Ogunlana; Shalom Nwodo Chinedu
Journal:  Sci Rep       Date:  2022-06-23       Impact factor: 4.996

Review 4.  Quercetin: A Bioactive Compound Imparting Cardiovascular and Neuroprotective Benefits: Scope for Exploring Fresh Produce, Their Wastes, and By-Products.

Authors:  Irshad Ul Haq Bhat; Rajeev Bhat
Journal:  Biology (Basel)       Date:  2021-06-26

5.  Terminalia catappa Extract Palliates Redox Imbalance and Inflammation in Diabetic Rats by Upregulating Nrf-2 Gene.

Authors:  Franklyn Nonso Iheagwam; Gaber El-Saber Batiha; Olubanke Olujoke Ogunlana; Shalom Nwodo Chinedu
Journal:  Int J Inflam       Date:  2021-12-16
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.